An initial review of CD276 expression in 408 BLCA specimens and 19 adjacent non-cancerous tissues revealed a markedly elevated level of CD276 in cancerous tissues (Figure 1, p<0.001). The gene discussed is CD276; the disease is bladder transitional cell carcinoma.